Correlation Between Pfizer and Innovator Nasdaq
Can any of the company-specific risk be diversified away by investing in both Pfizer and Innovator Nasdaq at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Innovator Nasdaq into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Innovator Nasdaq 100 Power, you can compare the effects of market volatilities on Pfizer and Innovator Nasdaq and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Innovator Nasdaq. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Innovator Nasdaq.
Diversification Opportunities for Pfizer and Innovator Nasdaq
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pfizer and Innovator is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Innovator Nasdaq 100 Power in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator Nasdaq 100 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Innovator Nasdaq. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator Nasdaq 100 has no effect on the direction of Pfizer i.e., Pfizer and Innovator Nasdaq go up and down completely randomly.
Pair Corralation between Pfizer and Innovator Nasdaq
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Innovator Nasdaq. In addition to that, Pfizer is 3.0 times more volatile than Innovator Nasdaq 100 Power. It trades about -0.16 of its total potential returns per unit of risk. Innovator Nasdaq 100 Power is currently generating about 0.13 per unit of volatility. If you would invest 6,073 in Innovator Nasdaq 100 Power on August 28, 2024 and sell it today you would earn a total of 167.00 from holding Innovator Nasdaq 100 Power or generate 2.75% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. Innovator Nasdaq 100 Power
Performance |
| Timeline |
| Pfizer Inc |
| Innovator Nasdaq 100 |
Pfizer and Innovator Nasdaq Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Innovator Nasdaq
The main advantage of trading using opposite Pfizer and Innovator Nasdaq positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Innovator Nasdaq can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator Nasdaq will offset losses from the drop in Innovator Nasdaq's long position.| Pfizer vs. Capricor Therapeutics | Pfizer vs. Soleno Therapeutics | Pfizer vs. Bio Path Holdings | Pfizer vs. Moleculin Biotech |
| Innovator Nasdaq vs. Innovator Nasdaq 100 Power | Innovator Nasdaq vs. Innovator Growth 100 Power | Innovator Nasdaq vs. Innovator Nasdaq 100 Power | Innovator Nasdaq vs. Innovator Russell 2000 |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |